NanoBioCel Research Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV-EHU), Vitoria-Gasteiz, Spain; Bioaraba, NanoBioCel Research Group, Vitoria-Gasteiz, Spain.
NanoBioCel Research Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV-EHU), Vitoria-Gasteiz, Spain; Bioaraba, NanoBioCel Research Group, Vitoria-Gasteiz, Spain; Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN). Institute of Health Carlos III, Madrid, Spain.
Adv Drug Deliv Rev. 2024 Jul;210:115342. doi: 10.1016/j.addr.2024.115342. Epub 2024 May 24.
Chronic non-healing wounds persist as a substantial burden for healthcare systems, influenced by factors such as aging, diabetes, and obesity. In contrast to the traditionally pro-regenerative emphasis of therapies, the recognition of the immune system integral role in wound healing has significantly grown, instigating an approach shift towards immunological processes. Thus, this review explores the wound healing process, highlighting the engagement of the immune system, and delving into the behaviors of innate and adaptive immune cells in chronic wound scenarios. Moreover, the article investigates biomaterial-based strategies for the modulation of the immune system, elucidating how the adjustment of their physicochemical properties or their synergistic combination with other agents such as drugs, proteins or mesenchymal stromal cells can effectively modulate the behaviors of different immune cells. Finally this review explores various strategies based on synthetic and biological nanostructures, including extracellular vesicles, to finely tune the immune system as natural immunomodulators or therapeutic nanocarriers with promising biophysical properties.
慢性难愈性创面给医疗系统带来了沉重负担,其发生与发展受老龄化、糖尿病、肥胖等多种因素影响。与传统再生治疗方法不同,人们逐渐认识到免疫系统在创面愈合中的重要作用,这促使治疗方法发生转变,从关注创面修复本身转变为关注创面微环境中的免疫调节。因此,本综述探讨了创面愈合过程,强调了免疫系统的参与,并深入研究了固有免疫和适应性免疫细胞在慢性创面中的行为。此外,文章还探讨了基于生物材料的免疫调节策略,阐明了如何通过调整其物理化学性质或与药物、蛋白质或间充质基质细胞等其他药物联合使用来有效调节不同免疫细胞的行为。最后,本文还探讨了基于合成和生物纳米结构的各种策略,包括细胞外囊泡,以作为天然免疫调节剂或具有良好生物物理性质的治疗性纳米载体来精细调节免疫系统。